shares-of-ranbaxy - Latest News on shares-of-ranbaxy | Read Breaking News on Zee News

Ranbaxy shares dive nearly 20% on USFDA restrictions

Last Updated: Friday, January 24, 2014, 18:24

At the NSE, Ranbaxy's scrip tanked 18.94 percent to close the day at Rs 338.40.

Ranbaxy extends loss, down over 2% on FDA concerns

Last Updated: Tuesday, January 14, 2014, 13:19

Shares of Ranbaxy Laboratories on Tuesday fell by over 2 percent after the USFDA raised concerns about manufacturing practices at the pharmaceutical firm's Toansa plant in Punjab.

Ranbaxy slips over 5% on FDA concerns about Toansa plant

Last Updated: Monday, January 13, 2014, 18:51

After plunging 9.37 percent to Rs 420 in intra-day trade, the pharma major's scrip finally ended at Rs 438.35, down 5.42 percent at the BSE.

Ranbaxy seeks to assuage shareholders' worries

Last Updated: Friday, September 20, 2013, 22:46

Drug major Ranbaxy Laboratories Friday sought to assuage concerns of shareholders in the wake of company's stock price taking a hard knock after the US Food and Drug Administration banned the import of drugs from its Mohali plant.

Certain consent decree terms to apply to Mohali unit: Ranbaxy

Last Updated: Tuesday, September 17, 2013, 19:16

"The FDA also ordered that the Mohali facility be subject to certain terms of the consent decree of permanent injunction entered against Ranbaxy in January 2012," according to United States Food and Drug Administration website.

US import alert on Ranbaxy; Mohali unit part of consent decree

Last Updated: Monday, September 16, 2013, 23:54

"The firm will remain on the import alert until the company complies with U.S. Drug manufacturing requirements, known as current good manufacturing practices (CGMP)," USFDA said in a statement.

Ranbaxy falls about 30% after FDA import alert

Last Updated: Monday, September 16, 2013, 10:03

A third Ranbaxy Laboratories plant in India has been sanctioned with an import alert ban from the US Food and Drug Administration, triggering the worst single day fall in its stock on Monday and a brokerage downgrade.

Ranbaxy shares dive over 9% after Daiichi says misled over probes

Last Updated: Thursday, May 23, 2013, 12:57

Following the weakness in the stock, the market value of the company slipped by Rs 1,527 crore to Rs 16,708 crore.

Ranbaxy recovers lost ground; shares end nearly 4% higher

Last Updated: Tuesday, May 14, 2013, 12:00

Shares of Ranbaxy Laboratories recovered from early losses and settled nearly 4 percent higher on hopes that settlement of its long lawsuit in the US would be positive for drug maker the in the long term.